Medicare Just Started Covering GLP-1 Weight Loss Drugs — Here’s What That Means If You Don’t Qualify
Medicare now covers GLP-1 weight loss drugs for eligible seniors — here’s who qualifies, and options for everyone else.
Aesthetic Medicine News
New Mid-Face Filler Evolysse Sculpt Outperformed Restylane in Trial — Here’s What’s Coming
A new hyaluronic acid filler for mid-face volume, Evolysse Sculpt, outperformed Restylane-Lyft in a 304-patient clinical trial and is now under FDA review. Here’s what the data shows and what it could mean once it reaches the market.
FDA Approves SKINVIVE by JUVÉDERM for Neck Lines, Capping a Three-Year Path From Cheeks to “Tech Neck”
The FDA has approved SKINVIVE by JUVÉDERM for horizontal neck lines — the first hyaluronic acid injectable indicated specifically for the neck. Here’s the three-year regulatory path that got it here, what the trial data shows, and a key gap in who it’s been studied in.
New 2026 GLP-1 Study Shows Why Strength and Movement Still Matter During Weight Loss
A new GLP-1 study suggests that movement and strength support remain important during medical weight loss. Here’s what patients should know about staying active while using medications like Ozempic, Wegovy, Mounjaro and Zepbound.
New 2026 GLP-1 Study Shows Why Strength and Movement Still Matter During Weight Loss Read More »
Health Canada Approves BOEY: What a New Short-Acting Neuromodulator Could Mean for Aesthetic Patients
Health Canada has approved BOEY, a new short-acting neuromodulator from Allergan Aesthetics. Here’s what aesthetic patients should know about how it may compare with Botox, Dysport, and other wrinkle relaxers.
